Delineating the genetic and environmental risk factors in autoimmune diseases
Transcriptome profiling of immune cells in thymus with focus on autoimmune risk loci
Immunogenetic studies of CFS/ME
Functional genomic studies of chronic low back pain patients with modic changes and response to antibiotic treatment
Epigenetic (methylation and microRNA) and transcriptomic studies of disease activity and treatment response in rheumatoid arthritis and other phenotypes
Characterization of coagulation factors role in cancer
Hemothrombogenomics: Delineating the genetic cause in patients with inherited bleeding or thrombotic disease
Recent publications
Tapia G, Mortimer G, Ye J, Gillard BT, Chipper-Keating S, Mårild K, Viken MK, Lie BA, Joner G, Skrivarhaug T, Njølstad PR, Størdal K, Gillespie KM, Stene LC(2019) Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes Pediatr Diabetes(in press) DOI 10.1111/pedi.12875, PubMed 31173445
Kjeldsen-Kragh J, Titze TL, Lie BA, Vaage JT, Kjær M(2019) HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women Blood Adv, 3(7), 945-951 DOI 10.1182/bloodadvances.2019032227, PubMed 30923048
Tapia G, Mårild K, Dahl SR, Lund-Blix NA, Viken MK, Lie BA, Njølstad PR, Joner G, Skrivarhaug T, Cohen AS, Størdal K, Stene LC(2019) Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes Diabetes Care, 42(4), 553-559 DOI 10.2337/dc18-2176, PubMed 30692241